|
|
Volumn 58, Issue 2, 1997, Pages 87-88
|
|
SSRI optimal dose remains at issue [2]
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
FLUOXETINE;
PAROXETINE;
PLACEBO;
SEROTONIN UPTAKE INHIBITOR;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DEPRESSION;
DOSE RESPONSE;
HAMILTON SCALE;
HUMAN;
LETTER;
MAJOR CLINICAL STUDY;
MENTAL DISEASE;
PRIORITY JOURNAL;
PSYCHOPHARMACOTHERAPY;
RANDOMIZED CONTROLLED TRIAL;
RATING SCALE;
TREATMENT OUTCOME;
|
|
EID: 0031037841
PISSN: 01606689
EISSN: None
Source Type: Journal
DOI: 10.4088/JCP.v58n0206d Document Type: Letter |
|
Times cited : (8)
|
|
References (8)
|